Document is current
Any future updates will be listed below
-
Authors
Kadibalban, A Samer https://orcid.org/0009-0001-9726-543X
Künstner, Axel https://orcid.org/0000-0003-0692-2105
Schröder, Torsten https://orcid.org/0009-0006-4897-1481
Zauleck, Julius https://orcid.org/0009-0002-1391-5755
Witt, Oliver https://orcid.org/0009-0000-8665-9137
Marinos, Georgios https://orcid.org/0000-0002-6443-7696
Kaleta, Christoph https://orcid.org/0000-0001-8004-9514
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC2167)
ExoMod (KA 3541/20-1)
- License Information
-
More Information
Article History
Received: 10 January 2025
Revised: 11 March 2025
Accepted: 31 March 2025
First Online: 22 April 2025
Disclosure and competing interests statement
: Perfood, founded in 2017, is a MedTech startup that develops medical and lifestyle products aimed at preventing or treating diseases, as well as facilitating healthy lifestyle changes. The core approach is based on precise monitoring of lifestyle factors through the use of sensors, microbiome data and user input, enabling the delivery of personalised recommendations. The data used in this publication comes exclusively from Perfood’s lifestyle product, MillionFriends. The co-authors, Axel Künstner, Torsten Schröder, Julius Zauleck, and Oliver Witt, are affiliated with Perfood GmbH. The authors declare no competing or commercial interests. The data for this study were collected up to 2021, and the microbiome data is not part of any product by Perfood GmbH as of today.
